Detalhe da pesquisa
1.
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy.
J Infect Dis
; 229(3): 743-752, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349333
2.
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
J Infect Dis
; 225(5): 856-861, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562096
3.
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.
Nat Med
; 26(4): 519-528, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284611